BAD-Glucokinase Axis Regulates Platelet Activation and Thrombosis
Arteriosclerosis, Thrombosis, and Vascular Biology · 2025
DOI: 10.1161/atvbaha.124.321738 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2025. Verfasst von Mengnan Yang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Institute of Hematology, Cyrus Tang Medical Institute, The First Affiliated Hospital and Collaborative Innovation Center of Hematology, Suzho…. Hauptthemen laut MEDLINE: Blood Platelets, Thrombosis, Platelet Activation, bcl-Associated Death Protein. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: BAD (Bcl2-associated death promoter), a member of the Bcl2 proapoptotic family, promotes cell apoptosis by sequestering the prosurvival proteins Bcl-XL and Bcl2 from the proapoptotic proteins BAK (Bcl2 homologous antagonist/killer) and BAX (Bcl2-associated X protein) in nucleated cells. BAD is also expressed in platelets, playing a role in regulating platelet lifespan, apoptosis, and clearance. However, whether BAD regulates platelet activation and arterial thrombosis remains unclear. METHODS: The role of BAD in platelet activation and arterial thrombosis was investigated using BAD-deficient mice ( Bad −/− ), in vitro functional studies, and arterial thrombosis models. The regulatory effect of BAD on platelet energy metabolism was detected using a Seahorse Extracellular Flux Analyzer. The regulatory effect of BAD on glucokinase was investigated by coimmunoprecipitation and activity measurement. The glucokinase heterozygous knockout mice ( Gck +/− ) and activator were used to study its role in platelet activation. RESULTS: BAD-deficient mice ( Bad −/− ) and wild-type mice transfused with Bad −/− platelets displayed prolonged tail bleeding and arterial occlusion times. Bad −/− platelets exhibited decreased aggregation in response to stimulations by proteinase-activated receptor 4-activating peptide, thrombin, and U46619. Furthermore, BAD ablation suppressed platelet integrin α IIb β 3 activation, granule secretion, and clot retraction induced by these agonists. Mechanistically, BAD interacted with glucokinase, and BAD deficiency resulted in decreased platelet glucokinase activity, mitochondrial oxidative phosphorylation, and mitochondrial ATP production. The partial loss of glucokinase ( Gck +/− ) phenocopied platelet function defects caused by BAD deficiency, and a glucokinase activator rescued the impaired mitochondrial ATP production and function of Bad −/− platelets. Additionally, the glucokinase activator enhanced human platelet activation. CONCLUSIONS: Our findings demonstrate the critical role of the BAD-glucokinase axis in platelet activation and thrombosis, suggesting a potential target for antithrombotic therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Institute of Hematology, Cyrus Tang Medical Institute, The First Affiliated Hospital and Collaborative Innovation Center of Hematology, Suzhou Medical College, Soochow University, Key Laboratory of Thrombosis an…
ORCID-Profile: Kesheng Dai, Rong Yan
Zitieren
APA
Yang, M., Chen, S., Li, Q., Zhou, K., Li, Y., Sun, C., Xia, Y., Tan, J., Huang, Q., Jin, Y., Hu, R., Ruan, C., Dai, K., & Yan, R. (2025). BAD-Glucokinase Axis Regulates Platelet Activation and Thrombosis. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.124.321738
Vancouver
Yang M, Chen S, Li Q, Zhou K, Li Y, Sun C, et al. BAD-Glucokinase Axis Regulates Platelet Activation and Thrombosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 2025. doi:10.1161/atvbaha.124.321738
BibTeX
@article{Yang2025,
author = {Yang, Mengnan and Chen, Shuang and Li, Qing and Zhou, Kangxi and Li, Yu and Sun, Chenglin and Xia, Yue and Tan, Jing and Huang, Qiuxia and Jin, Yuxin and Hu, Renping and Ruan, Changgeng and Dai, Kesheng and Yan, Rong},
title = {BAD-Glucokinase Axis Regulates Platelet Activation and Thrombosis},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2025},
doi = {10.1161/atvbaha.124.321738}
}
EUVIMED